Filing Details
- Accession Number:
- 0000897069-25-000130
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-29 16:20:23
- Reporting Period:
- 2025-01-27
- Accepted Time:
- 2025-01-29 16:20:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1533743 | Processa Pharmaceuticals Inc. | PCSA | Pharmaceutical Preparations (2834) | 451539785 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1799363 | Patrick Lin | C/O Processa Pharmaceuticals, Inc. 7380 Coca Cola Drive, Suite 106 Hanover MD 21076 | Chief Business - Strategy Off | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-01-27 | 43,500 | $0.80 | 43,500 | No | 4 | P | Indirect | Lin Family Trust Feb 4, 2024 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | Lin Family Trust Feb 4, 2024 |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 29,059 | Direct |
Billionaire Hedge Funds
